Inhibition of biofilm formation of Staphylococcus aureus and Candida albicans and dispersion of preformed biofilms of S. aureus by sporothioether mixture (14 and 15) and sporothriolide 8 at various concentrations; references [%].

Test organism		14 + 15 mixture	8
Biofilm inhibition [% ± SD]	S. aureus (DSM 1104)a	77 ± 9 (250 μg mL−1)	75 ± 8 (250 μg mL−1)
		24 ± 9 (62.5 μg mL−1)	55 ± 9 (3.9 μg mL−1)
			37 ± 10 (2 μg mL−1)
	C. albicans (DSM 11225)b	58 ± 8 (250 μg mL−1)	—
		40 ± 10 (31.3 μg mL−1)
Biofilm dispersion [% ± SD]	S. aureus (DSM 1104)c	77 ± 9 (250 μg mL−1)	53 ± 6 (250 μg mL−1)
		24 ± 9 (62.5 μg mL−1)	36 ± 5 (62.5 μg mL−1)

^aMicroporenic acid A, 74 ± 12 (250 μg mL⁻¹), 75 ± 6 (7.8 μg mL⁻¹), 42 ± 7 (3.9 μg mL⁻¹).

^bFarnesol: 75 ± 9 (250 μg mL⁻¹), 51 ± 7 (31.3 μg mL⁻¹), 38 ± 10.

^cMicroporenic acid A: 64 ± 7 (250 μg mL⁻¹), 41 ± 15 (15.6 μg mL⁻¹); SD: standard deviation; —no inhibition.